Utility of trio-based exome sequencing in the elucidation of the genetic basis of isolated syndromic intellectual disability: illustrative cases

Introduction Exome sequencing is recognized as a powerful tool for identifying the genetic cause of intellectual disability (ID). It is uncertain, however, whether only the exome of the proband should be sequenced or if the sequencing of parental genomes is also required, and the resulting increase in diagnostic yield justifies the increase in costs. Patients and methods We sequenced the exomes of eight individuals with sporadic syndromic ID and their parents. Results and discussion Likely pathogenic variants were detected in eight candidate genes, namely homozygous or compound heterozygous variants in three autosomal genes (ADAMTSL2, NALCN, VPS13B), one in an X-linked gene (MID1), and de novo heterozygous variants in four autosomal genes (RYR2, GABBR2, CDK13, DDX3X). Two patients harbored rare variants in two or more candidate genes, while in three other patients no candidate was identified. In five probands (62%), the detected variants explained their clinical findings. The causative recessive variants would have led to diagnosis even without parental exome sequencing, but for the heterozygous dominant ones, the exome trio-based approach was fundamental in the identification of the de novo likely pathogenic variants.

[1]  C. Depienne,et al.  Using medical exome sequencing to identify the causes of neurodevelopmental disorders: Experience of 2 clinical units and 216 patients , 2018, Clinical genetics.

[2]  François Dubeau,et al.  High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies. , 2017, American journal of human genetics.

[3]  K. Heimdal,et al.  Heterozygous mutations affecting the protein kinase domain of CDK13 cause a syndromic form of developmental delay and intellectual disability , 2017, Journal of Medical Genetics.

[4]  S. Mane,et al.  GABBR2 mutations determine phenotype in rett syndrome and epileptic encephalopathy , 2017, Annals of neurology.

[5]  D. Y. Sunaga,et al.  Exomic variants of an elderly cohort of Brazilians in the ABraOM database , 2017, Human mutation.

[6]  Joan,et al.  Prevalence and architecture of de novo mutations in developmental disorders , 2017, Nature.

[7]  Anke M Hövels,et al.  Effectiveness of whole-exome sequencing and costs of the traditional diagnostic trajectory in children with intellectual disability , 2016, Genetics in Medicine.

[8]  Ricardo Villamarín-Salomón,et al.  ClinVar: public archive of interpretations of clinically relevant variants , 2015, Nucleic Acids Res..

[9]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[10]  L. Vissers,et al.  Genetic studies in intellectual disability and related disorders , 2015, Nature Reviews Genetics.

[11]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[12]  Michael J Parker,et al.  Mutations in DDX3X Are a Common Cause of Unexplained Intellectual Disability with Gender-Specific Effects on Wnt Signaling. , 2015, American journal of human genetics.

[13]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[14]  M. Patterson,et al.  Whole-Exome Sequencing in the Clinic: Lessons from Six Consecutive Cases from the Clinician's Perspective , 2015, Molecular Syndromology.

[15]  Tom R. Gaunt,et al.  Ranking non-synonymous single nucleotide polymorphisms based on disease concepts , 2014, Human Genomics.

[16]  S. Haas,et al.  X-exome sequencing in Finnish families with Intellectual Disability - four novel mutations and two novel syndromic phenotypes , 2014, Orphanet Journal of Rare Diseases.

[17]  Jana Marie Schwarz,et al.  MutationTaster2: mutation prediction for the deep-sequencing age , 2014, Nature Methods.

[18]  S. Kantarci,et al.  X chromosome exome sequencing reveals a novel ALG13 mutation in a nonsyndromic intellectual disability family with multiple affected male siblings , 2014, American journal of medical genetics. Part A.

[19]  Wei Chen,et al.  Deep sequencing reveals 50 novel genes for recessive cognitive disorders , 2011, Nature.

[20]  Soma Das,et al.  Exome sequencing and the genetics of intellectual disability , 2011, Clinical genetics.

[21]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[22]  Lawrence H. Uricchio,et al.  Exome sequencing reveals a novel mutation for autosomal recessive non-syndromic mental retardation in the TECR gene on chromosome 19p13. , 2011, Human molecular genetics.

[23]  Christian Gilissen,et al.  A de novo paradigm for mental retardation , 2010, Nature Genetics.

[24]  H. Ropers.  Genetics of early onset cognitive impairment. , 2010, Annual review of genomics and human genetics.

[25]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[26]  J. Moeschler,et al.  Clinical Genetic Evaluation of the Child With Mental Retardation or Developmental Delays , 2006, Pediatrics.

[27]  Michael R. Johnson,et al.  De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. , 2014, American journal of human genetics.

[28]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.